Showing results (281-290 of 713) with videos related to
Sort By:
Pageof 72
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantationM Winkler, R Pichlmayr, P Neuhaus, et al.Oncogene|February 2, 1999
Microsatellite instability in European hepatocellular carcinomaM Salvucci, A Lemoine, R Saffroy, et al.Autoimmunity|January 1, 1991
Genes for interleukin-1, interleukin-6, and tumor necrosis factor are expressed at markedly reduced levels in the livers of patients with severe liver diseaseM G Tovey, J Gugenheim, J Guymarho, et al.Transplantation|March 27, 1995
The effects of donor and recipient endotoxemia on TNF alpha production and mortality in the rat model of syngenic orthotopic liver transplantationD Azoulay, I Astarcioglu, A Lemoine, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantationG Otto, J Bleyl, P Neuhaus, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinomaF Bertheault-Cvitkovic, F Lévi, S Soussan, et al.Annals of Surgery|November 7, 2000
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liverD Azoulay, D Castaing, J Krissat, et al.European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1989
Improved survival with splenic autotransplantation and fibronectin therapy following endotoxin administration in ratsF Calise, M Capron-Laudereau, J Gugenheim, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre studyB Ericzon, C Groth, H Bismuth, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipientsJ Devlin, R Williams, P Neuhaus, et al.Pageof 72